Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Bradley Pansing

Vascular Surgery Provo, UT Medical Doctor

NPI 1427553973 CMS profile 5706044

1034 N 500 W, Provo, UT 84604

Open in the dashboard

General payments

$3,057

27 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Bradley Pansing of Provo, UT is reported in the CMS Open Payments database as having received $3,057 across 27 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 38th percentile of Vascular Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $667 6
2024 General $1,400 11
2023 General $942 8
2022 General $48 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Bradley Pansing
  • Vascular Surgery median
  • Middle half of Vascular Surgery
  • National median

In program year 2025, general payments to Bradley Pansing were reported at $667. Among 3,991 Vascular Surgery profiles paid that year, the median was $924 and the middle half received between $273 and $2,636.

Show as a table
Year Bradley Pansing Vascular Surgery median Middle half National median
2019 $0 $796 $226–$2,363 $163
2020 $0 $348 $118–$1,110 $114
2021 $0 $471 $158–$1,421 $132
2022 $48 $725 $222–$2,183 $149
2023 $942 $836 $257–$2,440 $160
2024 $1,400 $909 $252–$2,619 $164
2025 $667 $924 $273–$2,636 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Medtronic, Inc. $1,213 7 payments
  2. W. L. Gore & Associates, Inc. $1,123 10 payments
  3. Penumbra, Inc. $163 1 payment
  4. Bolton Medical Inc $148 1 payment
  5. Silk Road Medical, Inc. $129 1 payment
  6. Solventum Corporation $117 1 payment
  7. Integra LifeSciences Corporation $60 2 payments
  8. Boston Scientific Corporation $50 1 payment
  9. Abbott Laboratories $22 1 payment
  10. Allergan Inc. $17 1 payment
  11. Other $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Food and Beverage $2,304 24 payments
  2. Education $753 3 payments
Products named General payments · program years 2022–2025
  1. ENDURANT IIS $953 6 payments
  2. GORE-TEX Vascular Graft $320 1 payment
  3. GORE TAG Thoracic Branch Endoprosthesis $283 2 payments
  4. GORE VIABAHN Endoprosthesis $182 1 payment
  5. GORE EXCLUDER Iliac Branch Endoprosthesis $178 2 payments
  6. Indigo System $163 1 payment
  7. TREO ABDOMINAL STENT-GRAFT SYSTEM $148 1 payment
  8. ENROUTE Transcarotid Neuroprotection System $129 1 payment
  9. ENROUTE Transcarotid Stent $129 1 payment
  10. GORE EXCLUDER AAA Endoprosthesis $125 1 payment
  11. Other $670 19 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

27 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Vascular Surgery in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record